HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adverse effects of propranolol treatment for infantile hemangiomas in China.

AbstractOBJECTIVES:
The β-blocker propranolol was discovered to be highly effective for the treatment of infantile hemangiomas (IHs), since 2008. Although some side effects have been reported earlier, no serious side effects of its use have been reported so far in Asia, especially in China. To determine the safety of this therapy, the side effects were analyzed in 97 infants who used propranolol (2 mg kg(-1)·d(-1)) against hemangioma from 2010 to 2011.
MATERIALS AND METHODS:
Routine blood and urine tests, hepatic and renal function tests, myocardial enzyme, electrolytes and blood sugar levels at baseline were performed. Electrocardiogram monitoring was performed 48 h after administration of the first dose (2 mg kg(-1)·d(-1)). Every patient (n = 97) was required to report to the hospital once a month.
RESULTS:
The following adverse effects were observed: bronchial hyperactivity (n = 5), cyanosis and cold extremities (n = 1), agranulocytosis (n = 1), and low body temperature (n = 1). These side effects were reported for the first time in Asia.
CONCLUSIONS:
Although propranolol is effective against IHs, its potential side effects should be considered and appropriate monitoring performed. Further studies need to be conducted to determine the optimal dose and duration of propranolol treatment for large and complex hemangiomas.
AuthorsDan Jian, Xiang Chen, Karishma Babajee, Juan Su, Jie Li, Xinling Hu, Hongfu Xie, Ji Li
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 25 Issue 5 Pg. 388-90 (Oct 2014) ISSN: 1471-1753 [Electronic] England
PMID23216314 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-Antagonists
  • Propranolol
Topics
  • Administration, Oral
  • Adrenergic beta-Antagonists (administration & dosage, adverse effects)
  • Bronchial Hyperreactivity (chemically induced)
  • China
  • Female
  • Hemangioma (drug therapy)
  • Humans
  • Infant
  • Male
  • Propranolol (administration & dosage, adverse effects)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: